Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:linaclotide
|
| gptkbp:approvalYear |
2012
|
| gptkbp:ATCCode |
gptkb:A06AX04
|
| gptkbp:contraindication |
pediatric patients under 6 years
known or suspected mechanical gastrointestinal obstruction |
| gptkbp:EuropeanBrandName |
gptkb:Constella
|
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
LINZESS
|
| gptkbp:indication |
chronic idiopathic constipation
irritable bowel syndrome with constipation |
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Allergan
gptkb:Ironwood_Pharmaceuticals |
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:mechanismOfAction |
guanylate cyclase-C agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
abdominal pain flatulence |
| gptkbp:bfsParent |
gptkb:Ironwood_Pharmaceuticals,_Inc.
|
| gptkbp:bfsLayer |
7
|